Anti-Microbial Resistance Market | Valued At USD 9,278.2 Million In 2022,

According to Precision Business Insights (PBI) latest report the global anti-microbial resistance market size was valued at USD 9,278.2 million in 2022 and is poised to grow at a significant CAGR of 6.1% during the forecast period 2023-2029. Global Anti-Microbial Resistance Market by Technology (Microbiology Culture, Immunoassay, PCR, NGS), By Pathogen, By End User, and Geography (North America, Europe, Asia-Pacific, and Rest of the World) Forecast to 2028. Key players' profiles in the Global Anti-Microbial Resistance Market report are Abacus Diagnostica, Abbott Laboratories, Accelerate Diagnostics, ADT Biotech, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Binx Health, bioMerieux Diagnostics, Bio-Rad Laboratories, Inc., Cepheid (Danaher), Curetis N.V./Curetis GmbH, Day Zero Diagnostics, Enzo Biochem, Eurofins Scientific, Fusion Genomics, GeneFluidics, Great Basin Corporation, Hologic. The global anti-microbial resistance industry is expanding because of rising antibiotics and multidrug resistance in poor and middle-income countries, pharmaceutical companies' significant investments in R&D, and an increase in the prevalence of infectious diseases. Major players' substantial investments and new advancements in the production of various end-use goods have provided lucrative revenue potential in developed markets. Furthermore, advances in nutrition, medicines, and immunization are projected to boost the anti-microbial resistance industry forward during the forecast period. The discovery of advanced prospect molecules and the introduction of novel combination therapies to treat anti-microbial-resistant are expected to propel market growth.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/anti-microbial-resistance-market/

PCR Segment Dominates the Anti-Microbial Resistance Market:
PCR accounts significant market share and is expected to grow with a significant CAGR from 2022-2028. The PCR segment is expected to grow drastically due to factors such as advancements in PCR technology, and high penetration of PCR technology due to high accuracy are the major factors contributing to the high segment share. In addition, increased adoption of PCR tests for HAIs such as MRSA is further fuelling segment expansion. Furthermore, the availability of robust and innovative product portfolios by leading market players is also expected to spur segment demand.

North America leads Anti-Microbial Resistance Market:
In North America, the anti-microbial resistance market holds the significant market share in 2022, and the market is expected to grow at a significant CAGR during the forecast period this is due to the high danger of developing antibiotic resistance, favourable government policies to address AMR, and the existence of cutting-edge healthcare infrastructure are all factors contributing to the rise of the North American region. Moreover, the increasing R&D to develop novel AMR procedures, the rising prevalence of infectious diseases, safety concerns, and technological advancements in antimicrobial products are the key factors supporting market growth in North America.
Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:

Aluminum Market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region.
In Nov-2022: Danaher Corporation came into partnership with Duke University, a research University. Under this partnership, Danaher Corporation aimed to shape Danaher Beacon for the development of Gene Therapy Innovation.
In Aug-2022: Becton, Dickinson, and Company entered a collaboration with Accelerate Diagnostics, Inc., a developer of rapid in-vitro diagnostics in microbiology. This Collaboration would enable the former company to help clinicians treat patients in a Constructive and organized way resulting in a decrease in costs in healthcare and helping restrict the stretch of antimicrobial resistance.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=65319

Key players in the Anti-Microbial Resistance Market Abacus Diagnostics, Abbott Laboratories, Accelerate Diagnostics, ADT Biotech, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Binx Health, bioMerieux Diagnostics, Bio-Rad Laboratories, Inc., Cepheid (Danaher), Curetis N.V./Curetis GmbH, Day Zero Diagnostics, Enzo Biochem, Eurofins Scientific, Fusion Genomics, GeneFluidics, Great Basin Corporation, Hologic

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.